Despite the impact of the ongoing COVID-19 pandemic, the Asia Pacific urological device market will continue to expand through 2029 due to growing patient awareness of urological treatments…
The COVID-19 global pandemic will have a significant impact on the Asia Pacific CRM device market in the short term, resulting in lost procedure volumes; however, following a period of recovery,…
The COVID-19 pandemic has an impact not only on the screening and elective interventional procedures but also on the overall healthcare system in the US. There is a limited negative impact on the…
A large undiagnosed patient population, rising PVD diagnosis rates, and growth in endovascular procedure volumes will support continued growth in the Latin American PV device market; however, cost…